While soft tissue sarcomas affect younger patients, few studies have assessed the distribution of underlying pathogenic germline variants.
No takes yet. Share an insight, caveat, or question.
Yndestad et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: